139 related articles for article (PubMed ID: 11389774)
1. CMV infection of liver transplant recipients: comparison of antigenemia and molecular biology assays.
Amorim ML; Cabeda JM; Seca R; Mendes AC; Castro AP; Amorim JM
BMC Infect Dis; 2001; 1():2. PubMed ID: 11389774
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of nucleic-acid-sequence- based amplification for the detection of cytomegalovirus infection in renal and liver transplant recipients.
Goossens VJ; Blok MJ; Christiaans MH; van Hooff JP; Sillekens P; Höckerstedt K; Lautenschlager I; Middeldorp JM; Bruggeman CA
Intervirology; 1999; 42(5-6):373-81. PubMed ID: 10702720
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification.
Blok MJ; Lautenschlager I; Goossens VJ; Middeldorp JM; Vink C; Höckerstedt K; Bruggeman CA
J Clin Microbiol; 2000 Dec; 38(12):4485-91. PubMed ID: 11101584
[TBL] [Abstract][Full Text] [Related]
4. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
[TBL] [Abstract][Full Text] [Related]
5. Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients.
Blank BS; Meenhorst PL; Pauw W; Mulder JW; van Dijk WC; Smits PH; Roeles F; Middeldorp JM; Lange JM
J Clin Virol; 2002 Jul; 25(1):29-38. PubMed ID: 12126719
[TBL] [Abstract][Full Text] [Related]
6. Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients.
Degré M; Kristiansen KI; Rollag H; Holter E; Nordal KP
Clin Microbiol Infect; 2001 May; 7(5):254-60. PubMed ID: 11422252
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.
Gerna G; Baldanti F; Lilleri D; Parea M; Alessandrino E; Pagani A; Locatelli F; Middeldorp J; Revello MG
J Clin Microbiol; 2000 May; 38(5):1845-53. PubMed ID: 10790111
[TBL] [Abstract][Full Text] [Related]
8. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.
Wirgart BZ; Claesson K; Eriksson BM; Brundin M; Tufveson G; Tötterman T; Grillner L
Clin Diagn Virol; 1996 Nov; 7(2):99-110. PubMed ID: 9137866
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.
Gerna G; Baldanti F; Middeldorp JM; Furione M; Zavattoni M; Lilleri D; Revello MG
J Clin Microbiol; 1999 Apr; 37(4):902-11. PubMed ID: 10074499
[TBL] [Abstract][Full Text] [Related]
13. Molecular-based strategies for assessment of CMV infection and disease in immunosuppressed transplant recipients.
Kulkarni A; Westmoreland D; Fox JD
Clin Microbiol Infect; 2001 Apr; 7(4):179-86. PubMed ID: 11422239
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants.
Preiser W; Bräuninger S; Schwerdtfeger R; Ayliffe U; Garson JA; Brink NS; Franck S; Doerr HW; Rabenau HF
J Clin Virol; 2001 Jan; 20(1-2):59-70. PubMed ID: 11163584
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial.
Gerna G; Baldanti F; Lilleri D; Parea M; Torsellini M; Castiglioni B; Vitulo P; Pellegrini C; Viganò M; Grossi P; Revello MG
Transplantation; 2003 Apr; 75(7):1012-9. PubMed ID: 12698090
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].
Özkarata E; Özbek ÖA; Avkan Oğuz V; Sayıner AA
Mikrobiyol Bul; 2016 Jan; 50(1):44-52. PubMed ID: 27058328
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus (CMV) Monitoring After Liver Transplantation: Comparison of CMV Pp65 Antigenemia Assay with Real-Time PCR Calibrated to WHO International Standard.
Kamei H; Ito Y; Onishi Y; Suzuki M; Imai H; Kurata N; Hori T; Tainaka T; Uchida H; Ogura Y
Ann Transplant; 2016 Mar; 21():131-6. PubMed ID: 26927444
[TBL] [Abstract][Full Text] [Related]
18. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
[TBL] [Abstract][Full Text] [Related]
19. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
Boeckh M; Huang M; Ferrenberg J; Stevens-Ayers T; Stensland L; Nichols WG; Corey L
J Clin Microbiol; 2004 Mar; 42(3):1142-8. PubMed ID: 15004066
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays.
Halwachs-Baumann G; Wilders-Truschnig M; Enzinger G; Eibl M; Linkesch W; Dornbusch HJ; Santner BI; Marth E; Kessler HH
J Clin Virol; 2001 Jan; 20(1-2):49-57. PubMed ID: 11163583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
